HCG
HCG is a clinically established gonadotropin hormone studied for fertility support, testicular function, and testosterone maintenance or recovery.
Overview
Human chorionic gonadotropin (HCG) is a glycoprotein hormone that mimics luteinizing hormone by binding LH receptors in the gonads. Unlike many entries in the peptide library, HCG does have FDA-approved medical uses and a substantial human clinical literature base.
The source protocol centers on a three-times-weekly maintenance pattern designed to preserve testicular function, support fertility, and maintain intratesticular testosterone during or after exogenous-androgen exposure.
At a Glance
Protocol
Standard three-times-weekly maintenance protocol using a consistent per-injection dose.
Inject three times weekly on non-consecutive days. HCG has a much longer half-life than endogenous LH, which is why a non-daily schedule can still provide sustained gonadal stimulation. Estradiol monitoring matters because HCG can increase aromatase-driven estrogen production in some users.
Dose progression
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
How HCG works.
HCG acts at LH receptors in Leydig cells and provides sustained stimulation of endogenous testosterone production because its half-life is far longer than native LH. It also helps preserve or restore intratesticular testosterone, which matters for fertility and testicular-volume goals.
The human evidence base here is stronger than for most research peptides. Clinical literature supports fertility, hypogonadotropic hypogonadism, and TRT-adjunct applications, especially when preserving spermatogenesis or reducing testicular atrophy is a major goal.
Effects
Observations from clinical or preclinical literature.
Caution
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
CoFactors
Life Factors
Complementary strategies for best outcomes.
Metrics
Day-to-day metrics worth tracking through the protocol.
- Total and free testosterone response - monitor labs and symptom changes
- Estradiol-related symptoms - watch water retention, breast sensitivity, or mood changes
- Testicular volume and function - useful where fertility or atrophy prevention is the target
- Injection-site reactions - note redness, swelling, or discomfort
Labs
Baseline and periodic bloodwork to monitor systemic health during the protocol.
Supplies Calculator
Estimates assume the schedule defined for this peptide.
Dose Calculator
Dose Calculator
Preparation
Careful technique preserves potency. Solution should be clear — do not shake.
- Allow vial to reach room temperature for 15–20 minutes before reconstitution.
- Draw the chosen bacteriostatic water volume with a sterile syringe.
- Inject slowly down vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
- Use within 30 days; discard any unused solution after 30 days.
Technique
General subcutaneous guidance from clinical best-practice resources.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Storage
Notes
Notes
References
- NCBI BookshelfHCG structure, function, and receptor biology overview.https://www.ncbi.nlm.nih.gov/books/NBK532950/
- Seminars in Reproductive MedicineHCG pharmacokinetic and pharmacodynamic discussion.https://pubmed.ncbi.nlm.nih.gov/11389057/
- JCEMCoviello et al., low-dose HCG maintaining intratesticular testosterone in men.https://pubmed.ncbi.nlm.nih.gov/15562020/
- Translational Andrology and UrologyhCG for hypogonadal male infertility review.https://pmc.ncbi.nlm.nih.gov/articles/PMC6087849/
- CDCSubcutaneous injection route guidance.https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf